Sirona Biochem Corp. Stock
Your prediction
Pros and Cons of Sirona Biochem Corp. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sirona Biochem Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sirona Biochem Corp. | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 2.000% | -0.488% | -7.692% | 105.025% | 22.892% | 9.677% | -66.281% |
| Celldex Therapeutics | -8.820% | -8.824% | -2.362% | 61.039% | 12.727% | -23.786% | 42.939% |
| Achieve Life Sciences Inc. | 8.270% | 10.722% | -29.062% | 17.763% | -27.432% | -54.684% | -72.462% |
Comments
News
Is Dentsply Sirona Stock a Buy After a Company Director Purchased 15,000 Shares?
Gregory T. Lucier, a member of the Board of Directors of Dentsply Sirona (NASDAQ:XRAY), reported the purchase of 15,000 shares of common stock at an average price of $12.45 per share on March 9
